Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Pharmaceutical Statistics
|
February 5, 2025
Sample Size Estimation for Correlated Count Data With Changes in Dispersion
Jintong Hou, Leslie A McClure, Savina Jaeger, et al.
Gastroenterology
|
August 3, 2011
Neurotensin signaling activates microRNAs-21 and -155 and Akt, promotes tumor growth in mice, and is increased in human colon tumors
Kyriaki Bakirtzi, Maria Hatziapostolou, Iordanes Karagiannides, et al.
Biological Psychiatry
|
September 6, 2006
Sleep problems, comorbid mental disorders, and role functioning in the national comorbidity survey replication
Thomas Roth, Savina Jaeger, Robert Jin, et al.
Archives of General Psychiatry
|
June 7, 2006
The prevalence and correlates of DSM-IV intermittent explosive disorder in the National Comorbidity Survey Replication
Ronald C Kessler, Emil F Coccaro, Maurizio Fava, et al.
Journal of Biomolecular Screening
|
February 13, 2014
Causal Network Models for Predicting Compound Targets and Driving Pathways in Cancer
Savina Jaeger, Junxia Min, Florian Nigsch, et al.
Oncotarget
|
December 10, 2013
Phosphoglycerate dehydrogenase is dispensable for breast tumor maintenance and growth
Jinyun Chen, Franklin Chung, Guizhi Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 7, 2019
A Phase I/II Trial of Carfilzomib, Pegylated Liposomal Doxorubicin, and Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma
Mark A Schroeder, Mark A Fiala, Eric Huselton, et al.
Biological Psychiatry
|
June 14, 2005
Patterns and predictors of attention-deficit/hyperactivity disorder persistence into adulthood: results from the national comorbidity survey replication
Ronald C Kessler, Lenard A Adler, Russell Barkley, et al.
Oncotarget
|
April 26, 2013
Targeting HSF1 sensitizes cancer cells to HSP90 inhibition
Yaoyu Chen, Jinyun Chen, Alice Loo, et al.
Cancer Discovery
|
February 13, 2018
Combined BRAF, EGFR, and MEK Inhibition in Patients with <i>BRAF</i><sup>V600E</sup>-Mutant Colorectal Cancer
Ryan B Corcoran, Thierry André, Chloe E Atreya, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Pharmaceutical Statistics
|
February 5, 2025
Sample Size Estimation for Correlated Count Data With Changes in Dispersion
Jintong Hou, Leslie A McClure, Savina Jaeger, et al.
Gastroenterology
|
August 3, 2011
Neurotensin signaling activates microRNAs-21 and -155 and Akt, promotes tumor growth in mice, and is increased in human colon tumors
Kyriaki Bakirtzi, Maria Hatziapostolou, Iordanes Karagiannides, et al.
Biological Psychiatry
|
September 6, 2006
Sleep problems, comorbid mental disorders, and role functioning in the national comorbidity survey replication
Thomas Roth, Savina Jaeger, Robert Jin, et al.
Archives of General Psychiatry
|
June 7, 2006
The prevalence and correlates of DSM-IV intermittent explosive disorder in the National Comorbidity Survey Replication
Ronald C Kessler, Emil F Coccaro, Maurizio Fava, et al.
Journal of Biomolecular Screening
|
February 13, 2014
Causal Network Models for Predicting Compound Targets and Driving Pathways in Cancer
Savina Jaeger, Junxia Min, Florian Nigsch, et al.
Oncotarget
|
December 10, 2013
Phosphoglycerate dehydrogenase is dispensable for breast tumor maintenance and growth
Jinyun Chen, Franklin Chung, Guizhi Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 7, 2019
A Phase I/II Trial of Carfilzomib, Pegylated Liposomal Doxorubicin, and Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma
Mark A Schroeder, Mark A Fiala, Eric Huselton, et al.
Biological Psychiatry
|
June 14, 2005
Patterns and predictors of attention-deficit/hyperactivity disorder persistence into adulthood: results from the national comorbidity survey replication
Ronald C Kessler, Lenard A Adler, Russell Barkley, et al.
Oncotarget
|
April 26, 2013
Targeting HSF1 sensitizes cancer cells to HSP90 inhibition
Yaoyu Chen, Jinyun Chen, Alice Loo, et al.
Cancer Discovery
|
February 13, 2018
Combined BRAF, EGFR, and MEK Inhibition in Patients with <i>BRAF</i><sup>V600E</sup>-Mutant Colorectal Cancer
Ryan B Corcoran, Thierry André, Chloe E Atreya, et al.
Page
of 2